The Program comprises a number of interactive and overlapping focus groups, which have continued to be productive, and form the basis for a high degree of interaction and collaboration. The Viral Oncogenesis focus group has a strong emphasis on the role of viruses as mediators of human cancers, including studies of Epstein-Barr virus (EBV), Kaposi's Sarcoma Herpesvirus (KSHV), human cytomegalovirus (HCMV), human papilloma virus (HPV) and hepatitis C virus (HCV), as well as other known tumor viruses: SV40 and Adenovirus. The DNA Virology focus group includes an excellent group of herpesvirus investigators who are studying herpes simplex viruses 1 and 2 and are focusing their work on viral infection and establishment of latency. The Retrovirology focus group studies HIV and AIDS-related malignancies as well as oncogenic murine retroviruses. The Viral Receptor focus group has strengths related to viral receptors and virus receptor interactions. The group includes members who have made major advances in understanding HIV receptors, avian leukosis virus (ALV) receptors and herpes simplex receptors. The General Virology focus group includes investigators studying Arbo-viruses, Corona-viruses and Bunya-viruses. Although not directly related to cancer, these investigators bring to the program expertise in RNA virology and classical virology, which have provided depth to the program and have proven vital for the general understanding of virus-host interactions. The general areas of viral-related research in the Tumor Virology Program include: 1) studies to determine the mechanisms mediating cellular transformation, immortalization and cell cycle dysregulation by viral encoded proteins;2) studies to understand the role of viral proteins on cellular and viral gene expression and on control of cell metabolism, growth and survival;3) research involving the structure and function of viral receptors and viral-receptor interactions;4) investigation of the molecular biology and pathogenesis of retroviruses as they relate to AIDS and AIDS-associated malignancies;5) studies focused on elucidation of the mechanisms of viral neuropathology;6) studies to develop viral vectors for human gene therapy and cancer;and 7) development of vaccine strategies for the treatment of viral-associated cancers.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016520-38
Application #
8593248
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2013-12-01
Budget End
2014-11-30
Support Year
38
Fiscal Year
2014
Total Cost
$97,336
Indirect Cost
$86,402
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Karunamuni, Roshan; Naha, Pratap C; Lau, Kristen C et al. (2016) Development of silica-encapsulated silver nanoparticles as contrast agents intended for dual-energy mammography. Eur Radiol 26:3301-9
Vachani, Anil; Wong, Yu-Ning; Israelite, Jennifer et al. (2016) Validation of Molecular Pathology Codes for the Identification of Mutational Testing in Lung and Colon Cancer. Med Care :
Ruella, Marco; Barrett, David M; Kenderian, Saad S et al. (2016) Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies. J Clin Invest 126:3814-3826
Dannoon, Shorouk; Ganguly, Tanushree; Cahaya, Hendry et al. (2016) Structure-Activity Relationship of (18)F-Labeled Phosphoramidate Peptidomimetic Prostate-Specific Membrane Antigen (PSMA)-Targeted Inhibitor Analogues for PET Imaging of Prostate Cancer. J Med Chem 59:5684-94
Kumar, Anita J; Gimotty, Phyllis A; Gelfand, Joel et al. (2016) Delays in postremission chemotherapy for Philadelphia chromosome negative acute lymphoblastic leukemia are associated with inferior outcomes in patients who undergo allogeneic transplant: An analysis from ECOG 2993/MRC UK ALLXII. Am J Hematol 91:1107-1112
Clark, A S; DeMichele, A; Mankoff, D (2016) HER2 imaging in the ZEPHIR study. Ann Oncol 27:555-7
Bartlett, Edmund K; Peters, Madalyn G; Blair, Anne et al. (2016) Identification of Patients with Intermediate Thickness Melanoma at Low Risk for Sentinel Lymph Node Positivity. Ann Surg Oncol 23:250-6
Walsh, Michael F; Nathanson, Katherine L; Couch, Fergus J et al. (2016) Genomic Biomarkers for Breast Cancer Risk. Adv Exp Med Biol 882:1-32
Heneghan, Mallorie B; Rheingold, Susan R; Li, Yimei et al. (2016) Treatment of Osteonecrosis in Children and Adolescents With Acute Lymphoblastic Leukemia. Clin Lymphoma Myeloma Leuk 16:223-229.e2
Flavell, Robert R; Truillet, Charles; Regan, Melanie K et al. (2016) Caged [(18)F]FDG Glycosylamines for Imaging Acidic Tumor Microenvironments Using Positron Emission Tomography. Bioconjug Chem 27:170-8

Showing the most recent 10 out of 848 publications